ISTA Pharmaceuticals, Inc. (NASDAQ: ISTA) today announced it had exceeded the $100 million revenue threshold with preliminary, unaudited net revenues ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE